Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Clinical trial NCT02548351 · TERMINATED
Trial details
- NCT number
- NCT02548351
- Sponsor
- Intercept Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-22
- Primary completion
- 2023-09-15
- Enrollment
- 2477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.